The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of ...
US FDA approves Puma Biotech's breast cancer treatment
(Reuters) - The U.S. Food and Drug Administration (FDA) on Monday approved Puma Biotechnology Inc's experimental breast cancer drug that lowers the risk of the disease returning after initial treatment. Shares of Los Angeles-based Puma Biotech jumped ...
No comments:
Post a Comment